Shortage of Fluoxetine (Medreich) 10 mg capsule

1 Feb 2024

Policy

Fluoxetine (Medreich ®) for the treatment of major depressive disorders and obsessive-compulsive disorder is now listed on the Pharmaceutical Benefits Scheme (PBS) for the current supply shortage under Section 19A.

For more information on Fluoxetine (Medreich ®), please contact the PBS directly.

More news & views

14 April 2025

Progress on manuscript submissions to peer-reviewed journals

RANZCP's Policy department's update on the progress on submissions of manuscripts to peer reviewed j...

10 April 2025

Exploring the state of academic psychiatry in Australia and Aotearoa New Zealand

24 March 2025

Authority requests via the online PBS authorities system

Read recent advice from Services Australia for requests via the Online PBS Authorities system.